獣医API製造の世界市場レポート 2024

獣医API製造の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.5%の年間複合成長率（CAGR）で104億1,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化獣医療の発展、世界市場の拡大、規制順守の重視の高まり、動物福祉の重要性の増大、ドラッグデリバリーシステムの革新、および栄養補助食品の市場需要の増大に起因します。この期間に予想される主な動向には、製造における技術の進歩、原薬（API）製造のアウトソーシングの増加、バイオテクノロジー主導のAPIへの移行、製造工程におけるデジタル化と自動化の統合、動物用API市場のグローバル化などが含まれます。

獣医物用原薬（API）製造市場の成長は、ペットの飼い主の数の増加によって牽引されると予想されます。ペットの飼い主、つまりペットの動物を所有または引き取る人は、ペットに必要不可欠な健康施設を提供するため、動物用医薬品の需要の増大に貢献しています。米国に本拠を置くペット製品のオンライン小売業者であるチューイ社は、2021年に米国で約977,202匹のペットが引き取られ、その結果、過去6年間で最も高い引き取り率61%を記録したと報告しました。このペットの所有者の急増により、獣医API製造市場の需要が大幅に高まりました。

人獣共通感染症の蔓延も、獣医API製造市場の成長を促進すると予想されるもう1つの要因です。人獣共通感染症は動物と人間の間で伝染する可能性があるため、その蔓延を防ぐために獣医用原薬を使用したワクチンの開発が必要です。獣医物用原薬の使用は、人獣共通感染症の治療における主要な懸念である抗生物質耐性と闘う上で極めて重要です。外交問題評議会（CFR）によると、新たに発見された感染症または新興感染症の最大75%、および認識されている感染症の60%が人獣共通感染症を起源としています。人獣共通感染症は、毎年世界中で270万人の死亡者と25億人の病気の発症を引き起こしています。この憂慮すべき人獣共通感染症の蔓延は、獣医API製造市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の獣医API製造市場、サービスタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 社内
• 請負業務委託
• 世界の獣医API製造市場、合成タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 化学ベースAPI
• 生物学的API
• 非常に強力なAPI
• 世界の獣医API製造市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 駆虫薬
• 抗感染症薬
• ワクチン
• NSAID

第7章 地域および国の分析

• 世界の獣医API製造市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の獣医API製造市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医API製造市場の競合情勢
• 獣医API製造市場の企業プロファイル
  • Alivira Animal Health Limited
  • Excel Industries Limited
  • Ofichem Group BV
  • Afton Pharma
  • Jiangsu Lingyun Pharmaceutical Co. Ltd.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary active pharmaceutical ingredients manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary active pharmaceutical ingredients manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary active pharmaceutical ingredients manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Antiparasitic; Anti-Infectives; Vaccines; NSAIDs
• 2) By Service Type: In House; Contract Outsourcing
• 3) By Synthesis Type: Chemical Based API; Biological API; Highly Potent API
• Companies Mentioned: Alivira Animal Health Limited; Excel Industries Limited; Ofichem Group B.V.; Afton Pharma; Jiangsu Lingyun Pharmaceutical Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Manufacturing veterinary active pharmaceutical ingredients involves synthesizing APIs from raw materials using complex, multi-step methods utilizing advanced processing technologies.

The primary products within veterinary active pharmaceutical ingredients manufacturing encompass anti-infectives, vaccines, and NSAIDs. Active Pharmaceutical Ingredients (APIs) are the core elements of pharmaceutical medications that exert specific effects on the body, aiding in the treatment of diseases. Service types associated with this field include in-house production and contract outsourcing. Additionally, synthetic types of APIs comprise chemical-based APIs, biological APIs, and highly potent APIs. These categories delineate the diverse methodologies involved in producing these vital components for veterinary pharmaceuticals.

The veterinary active pharmaceutical ingredients manufacturing market research report is one of a series of new reports from The Business Research Company that provides veterinary active pharmaceutical ingredients manufacturing market statistics, including veterinary active pharmaceutical ingredients manufacturing industry global market size, regional shares, competitors with veterinary active pharmaceutical ingredients manufacturing market share, detailed veterinary active pharmaceutical ingredients manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary active pharmaceutical ingredients manufacturing industry. This veterinary active pharmaceutical ingredient manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary active pharmaceutical ingredients manufacturing market size has grown strongly in recent years. It will grow from $6.92 billion in 2023 to $7.52 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historic period in veterinary active pharmaceutical ingredients manufacturing can be attributed to several contributing factors. These include the upward trend in pet ownership, the implementation of stringent regulatory standards within the industry, heightened attention towards animal nutrition, substantial investments in research and development initiatives, and the overall expansion of the global economy. These elements collectively facilitated the growth trajectory witnessed in this sector during that period.

The veterinary active pharmaceutical ingredients manufacturing market size is expected to see strong growth in the next few years. It will grow to $10.41 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth during the forecast period stems from developments in personalized veterinary medicine, expanding global markets, heightened emphasis on regulatory adherence, the increasing significance of animal welfare, innovations in drug delivery systems, and a growing market demand for nutraceuticals. Key trends expected in this period encompass technological advancements in manufacturing, a rise in outsourcing of active pharmaceutical ingredient (API) production, a transition towards biotechnology-driven APIs, the integration of digitalization and automation in manufacturing processes, and the globalization of the veterinary API market.

The growth of the veterinary active pharmaceutical ingredients (API) manufacturing market is anticipated to be driven by the increasing number of pet owners. Pet owners, those who own or adopt pet animals, contribute to the growing demand for veterinary drugs as they provide essential health facilities to their pets. In 2021, Chewy, Inc., a US-based online retailer of pet products, reported approximately 977,202 pets adopted in the US, resulting in the highest adoption rate of 61% in the past six years. This surge in pet ownership significantly boosts the demand for the veterinary active pharmaceutical ingredients manufacturing market.

The rising prevalence of zoonotic diseases is another factor expected to fuel the growth of the veterinary active pharmaceutical ingredients manufacturing market. Zoonotic diseases, capable of transmission between animals and humans, necessitate the development of vaccines using veterinary APIs to prevent their spread. The use of veterinary APIs is crucial in combating antibiotic resistance, a major concern in treating zoonotic diseases. According to the Council on Foreign Relations (CFR), up to 75% of newly discovered or emerging infectious diseases and 60% of recognized infectious diseases have zoonotic origins. Zoonoses cause 2.7 million human fatalities and 2.5 billion episodes of disease worldwide annually. This alarming prevalence of zoonotic diseases is a driving force behind the growth of the veterinary active pharmaceutical ingredients manufacturing market.

Innovation in product development emerges as a key trend in the veterinary active pharmaceutical ingredient manufacturing market. Major players are prioritizing the creation of innovative products to maintain their market positions. For instance, in June 2021, Lasa Supergenerics Limited, an India-based active pharmaceutical ingredient (API) manufacturing company, introduced Oxyclozanide. This novel anthelmintic addresses fascioliasis, a topical worm infection primarily affecting ruminants such as cattle, goats, and sheep. Oxyclozanide, with its application in the veterinary industry, demonstrates substantial potential in both domestic and international markets, exemplifying the trend of product innovation in the veterinary active pharmaceutical ingredients manufacturing sector.

Prominent companies in the veterinary active pharmaceutical ingredient (API) manufacturing market are strategically investing in the establishment of manufacturing plants for APIs as a means to gain a competitive advantage. These manufacturing facilities specialize in producing active pharmaceutical ingredients utilized in the formulation of veterinary drugs. In October 2023, Stallen South Asia Private Limited, an India-based animal health company, initiated operations at a new veterinary API facility dedicated to Halquinol. Halquinol, a non-antibiotic growth promoter categorized as a hydroxyquinoline, is a combination of 5-chloro-8-hydroxyquinoline, 5,7-dichloro-8-hydroxyquinoline, and 7-chloro-8-hydroxyquinoline. The facility produces Halquinol 98%, manufactured in compliance with British Pharmacopeia 1980 (BP 80) guidelines. Stallen's product range includes Halquinol 98% as a chemical API used in veterinary formulations and feed additives. The introduction of this facility aims to reduce dependence on imports from China for the animal health industry, emphasizing a strategic shift in the sourcing of a wide range of APIs.

In June 2022, Orion Corporation, a Finland-based pharmaceutical company specializing in human and veterinary pharmaceuticals, completed the acquisition of Inovet (V.M.D. nv/sa) for $128.33 million (130 million euros). This strategic move positions Orion's Veterinary Medicines section to diversify its product portfolio and gain a presence in the production animal market. The acquisition also facilitates an expansion of Orion's geographical footprint in Western Europe and the export market. Inovet (V.M.D. nv. sa.) is a Belgium-based manufacturer of veterinary active pharmaceutical ingredients. This acquisition is expected to enhance Orion's capabilities and competitiveness in the veterinary API manufacturing market.

Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market report are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Afton Pharma, Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS - Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Albemarle Corporation, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi's Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Sante Animale S.A., Vetoquinol S.A., Virbac S.A.

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2023. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary active pharmaceutical ingredients manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary active pharmaceutical ingredients manufacturing market consists of revenues earned by entities by biologics and bulk drugs that are used to create components in medications which are responsible for the positive veterinary health impacts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Characteristics

3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends And Strategies

4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Growth

• 5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmentation

• 6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• In House
• Contract Outsourcing
• 6.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemical Based API
• Biological API
• Highly Potent API
• 6.3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antiparasitic
• Anti-Infectives
• Vaccines
• NSAIDs

7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Regional And Country Analysis

• 7.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 8.1. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 9.1. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 9.2. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 10.1. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 11.1. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 11.2. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 12.1. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 13.1. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 14.1. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 14.2. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 15.1. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 15.2. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 16.1. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 17.1. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 18.1. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 19.1. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 20.1. Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 21.1. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 21.2. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 22.1. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 23.1. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 23.2. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 24.1. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 24.2. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 25.1. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 25.2. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 26.1. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 26.2. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 27.1. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 28.1. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 28.2. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market

• 29.1. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
• 29.2. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape
• 30.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Company Profiles
  • 30.2.1. Alivira Animal Health Limited
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Excel Industries Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Ofichem Group B.V.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Afton Pharma
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Jiangsu Lingyun Pharmaceutical Co. Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Benchmarking

32. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market

34. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Future Outlook and Potential Analysis

• 34.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer